While immunotherapy-especially immune checkpoint blockade-seems to have limited effect on blood cancers, TGFβ1 was shown to be deeply involved in the pathogenesis of these cancer types11,12. Here, TGFB1 is linked to hematopoietic and lymphoid system neoplasm.